| scholarly article | Q13442814 |
| P50 | author | Housheng Hansen He | Q57718297 |
| Shannon M Bailey | Q91376581 | ||
| Meredith M Regan | Q99564359 | ||
| Myles Brown | Q30347463 | ||
| P2093 | author name string | J Dirk Iglehart | |
| Andrew H Beck | |||
| Laura C Collins | |||
| Andrea Richardson | |||
| Aquila Fatima | |||
| Gilles Buchwalter | |||
| Lauren Gilmore | |||
| Lillian Werner | |||
| Rinath M Jeselsohn | |||
| Steven E Come | |||
| P2860 | cites work | Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer. | Q50781854 |
| Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumour. | Q51059826 | ||
| Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial. | Q51357213 | ||
| Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters. | Q53582952 | ||
| Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer | Q79572358 | ||
| A phase II placebo-controlled trial of neoadjuvant anastrozole alone or with gefitinib in early breast cancer | Q80750218 | ||
| A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
| Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1 | Q28260929 | ||
| About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-alpha gene (ESR1) in breast cancer | Q28262312 | ||
| A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer | Q28297827 | ||
| Direct multiplexed measurement of gene expression with color-coded probe pairs | Q29614417 | ||
| Can the pharmaceutical industry reduce attrition rates? | Q29616077 | ||
| Supervised risk predictor of breast cancer based on intrinsic subtypes | Q29617404 | ||
| Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy | Q29618033 | ||
| Estrogen and progestin regulation of cell cycle progression | Q33923687 | ||
| Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer | Q33996115 | ||
| Peroxisome proliferator-activated receptor gamma negatively regulates IFN-beta production in Toll-like receptor (TLR) 3- and TLR4-stimulated macrophages by preventing interferon regulatory factor 3 binding to the IFN-beta promoter | Q34568504 | ||
| Cross-talk among estrogen receptor, epidermal growth factor, and insulin-like growth factor signaling in breast cancer. | Q34578377 | ||
| Macrophages regulate the angiogenic switch in a mouse model of breast cancer | Q34582812 | ||
| Breast cancer hormone receptor assay results of core needle biopsy and modified radical mastectomy specimens from the same patients | Q34640721 | ||
| Anti-inflammatory actions of adrenomedullin through fine tuning of HIF stabilization. | Q35003232 | ||
| Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response. | Q35049828 | ||
| Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group | Q35552069 | ||
| IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs | Q35685426 | ||
| Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome | Q36310475 | ||
| Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance | Q36957198 | ||
| Angiogenesis and inflammation in invasive carcinoma of the breast | Q37210559 | ||
| Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components | Q37802820 | ||
| Assessment accuracy of core needle biopsy for hormone receptors in breast cancer: a meta-analysis | Q38004852 | ||
| Leukotriene D4 enhances tumor necrosis factor-α-induced vascular endothelial growth factor production in human monocytes/macrophages | Q39560639 | ||
| Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer | Q40110155 | ||
| Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial | Q44045676 | ||
| Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival | Q45258324 | ||
| Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC). | Q45943410 | ||
| Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers | Q46818933 | ||
| Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study | Q48394963 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biopsy | Q179991 |
| P304 | page(s) | e64225 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Digital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune response | |
| P478 | volume | 8 |
| Q50955504 | Fibrotic focus: An important parameter for accurate prediction of a high level of tumor-associated macrophage infiltration in invasive ductal carcinoma of the breast. |
| Q36758456 | Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas |
| Q28077637 | Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women |
| Q47217714 | Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis. |
| Q102141449 | Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07) |
| Q37650129 | Polyisoprenylated methylated protein methyl esterase overexpression and hyperactivity promotes lung cancer progression |
| Q37072929 | Tumour sampling method can significantly influence gene expression profiles derived from neoadjuvant window studies |
| Q54959223 | Waveband specific transcriptional control of select genetic pathways in vertebrate skin (Xiphophorus maculatus). |
Search more.